KPIs & Operating Metrics(New)
Breakdown Of AssetsCommercial Operations Revenue By CategoryConsumer Healthcare Revenue BreakdownConsumer Healthcare Revenue Breakdown AnnualContractual ObligationsEmployee StatisticsEmployee Statistics %Established Pharmaceuticals Revenue BreakdownEstablished Vaccines Revenue BreakdownGeneral Medicines By CategoryGeneral Medicines Revenue By RegionGeneral Medicines Revenue By Region AnnualHiv & Immuno Inflammation Revenue BreakdownHiv & Immuno Inflammation Revenue Breakdown AnnualHiv Revenue BreakdownHiv Revenue Breakdown AnnualMeningitis, Influenza & Shingles Revenue BreakdownMeningitis Revenue BreakdownMeningitis Revenue Breakdown AnnualNon Current Assets By Location Of SubsidiaryNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Oncology Revenue BreakdownOncology Revenue Breakdown AnnualOperating Assets By SegmentOperating Margin By Segment %Operating Profit By SegmentOpex As A % Of RevenueOPEX SegregationOther General Medicines Revenue BreakdownOther General Medicines Revenue Breakdown AnnualPharmaceuticals Revenue BreakdownPharmaceuticals Revenue Breakdown AnnualProfit By Segment AnnualProfit Margin By Segment Annual %Purchase Commitments AnnualRespiratory/Immunology And Other Revenue BreakdownRespiratory/Immunology And Other Revenue Breakdown AnnualRespiratory Revenue BreakdownRespiratory Revenue Breakdown General MedicinesRespiratory Revenue Breakdown General Medicines AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By RegionRevenue By Region %Revenue By Region % Annual %Revenue By Region AnnualRevenue By SegmentRevenue By Segment %Revenue By Segment % Annual %Revenue By Segment AnnualSpeciality Medicines Revenue By RegionSpeciality Medicines Revenue By Region AnnualVaccines Revenue BreakdownVaccines Revenue Breakdown Annual
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Total Debt Growth (1y)Total Debt Growth (3y)Total Debt Growth (5y)
Income Statement
Gsk (GSK) Asset Utilization Ratio (2018)
Generated on {Timestamp}
© BusinessQuant.com
Generated on {Timestamp}
Powered by 
Peer Comparison
Historic Data
Download Data 🔒| Date | Value |
|---|---|